According to the information provided, the patient's COPD can be considered moderate or severe. Hence, this examination is because of the massive decrease in FEV1, which is 64% predicted pre-bronchodilator and 66% post-bronchodilator value, as well as sustained dyspnea and cough signs (Bollmeier & Hartmann, 2020). According to the GOLD guidelines, moderate disease severity is determined by a 50 -79 % FEV1 of predicted, and any reading below an index value of 50% defines severe COPD (Bollmeier & Hartmann, 2020). The patient's status at the
Get 20% discount on your first order